Castle Biosciences (CSTL) Cash from Financing Activities (2018 - 2026)
Castle Biosciences' (CSTL) quarterly Cash from Financing Activities came in at -$886000.0 in Q2 2026, down 977.23% year-over-year from $101000.0 in Q2 2025, and up 82.4% quarter-over-quarter from -$5.0 million in Q1 2026.
Powered by 
Analysis
Castle Biosciences (CSTL) Cash from Financing Activities (2018 - 2026) Analysis & Trends
Castle Biosciences has disclosed Cash from Financing Activities across 9 years of filings, most recently posting -$886000.0 for Q2 2026.
- In Q2 2026, Cash from Financing Activities fell 977.23% year-over-year to -$886000.0; the TTM figure through Jun 2026 stood at -$11.4 million (down 90.48% YoY), while the FY2025 annual figure was -$7.0 million, down 213.37% from the prior year.
- Cash from Financing Activities came in at -$886000.0 for Q2 2026 at Castle Biosciences, up from -$5.0 million in the prior quarter.
- In the past five years, Cash from Financing Activities ranged from a high of $10.6 million in Q1 2024 to a low of -$5.4 million in Q4 2024.
- Average Cash from Financing Activities over 5 years is -$417944.4, with a median of $43500.0 recorded in 2023.
- Year-over-year, Cash from Financing Activities jumped 1762.22% in 2024 and sank 977.23% in 2026.
- Over 5 years, Cash from Financing Activities stood at -$750000.0 in 2022, then tumbled by 339.6% to -$3.3 million in 2023, then plunged by 63.33% to -$5.4 million in 2024, then rose by 14.78% to -$4.6 million in 2025, then surged by 80.69% to -$886000.0 in 2026.
- Per Business Quant data, the three most recent Cash from Financing Activities figures were -$886000.0 in Q2 2026, -$5.0 million in Q1 2026, and -$4.6 million in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Natera | 53.05 Bn | 51.95 Bn | 486.15 Mn | 12.21 Mn |
| 2 | Quest Diagnostics | 27.19 Bn | 26.87 Bn | 1.03 Bn | -229.00 Mn |
| 3 | Labcorp Holdings | 25.93 Bn | 25.81 Bn | 1.11 Bn | -919.90 Mn |
| 4 | Guardant Health | 23.97 Bn | 22.91 Bn | 219.03 Mn | 23.01 Mn |
| 5 | Tempus AI | 13.64 Bn | 12.82 Bn | 274.25 Mn | 97.12 Mn |
| 6 | Caris Life Sciences | 8.47 Bn | 7.68 Bn | 182.38 Mn | -36.90 Mn |
| 7 | Sotera Health | 5.35 Bn | 4.99 Bn | 177.96 Mn | -2.41 Mn |
| 8 | BillionToOne | 4.96 Bn | 4.41 Bn | 77.11 Mn | 6.09 Mn |
| 9 | Adaptive Biotechnologies | 4.55 Bn | 4.21 Bn | 51.39 Mn | 142.19 Mn |
| 10 | Castle Biosciences | 1.08 Bn | 811.36 Mn | 79.85 Mn | -886,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -886,000.00 |
| Mar 31, 2026 | -5.03 Mn |
| Dec 31, 2025 | -4.59 Mn |
| Sep 30, 2025 | -919,000.00 |
| Jun 30, 2025 | 101,000.00 |
| Mar 31, 2025 | -1.55 Mn |
| Dec 31, 2024 | -5.39 Mn |
| Sep 30, 2024 | 838,000.00 |
| Jun 30, 2024 | 42,000.00 |
| Mar 31, 2024 | 10.64 Mn |
| Dec 31, 2023 | -3.30 Mn |
| Sep 30, 2023 | 45,000.00 |
| Jun 30, 2023 | 226,000.00 |
| Mar 31, 2023 | 728,000.00 |
| Dec 31, 2022 | -750,000.00 |
| Sep 30, 2022 | 388,000.00 |
| Jun 30, 2022 | 661,000.00 |
| Mar 31, 2022 | 1.22 Mn |
| Dec 31, 2021 | 126,000.00 |
| Sep 30, 2021 | 1.89 Mn |
API Access
Castle Biosciences Cash from Financing Activities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=CSTL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-from-financing-activities", "ticker": "CSTL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=CSTL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();